Skip to main content
. 2016 Sep 23;17(10):1618. doi: 10.3390/ijms17101618

(a)

Duration of NNM Administration Gefitinib Administration N BrdU-LI FAH, % BrdU-LI Extrafocal Liver Tissue, %
3 months 7 68.26 ± 6.82 § 18.07 ± 2.72
3 months 2 weeks HD 7 60.80 ± 2.80 § 18.33 ± 2.88
3 months 3 months LD 7 55.49 ± 3.00 § 12.53 ± 1.29